CSGCX
Price
$45.98
Change
-$0.13 (-0.28%)
Updated
Oct 7 closing price
Net Assets
1.46B
RLBCX
Price
$38.68
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

CSGCX vs RLBCX

Header iconCSGCX vs RLBCX Comparison
Open Charts CSGCX vs RLBCXBanner chart's image
Calvert Balanced C
Price$45.98
Change-$0.13 (-0.28%)
VolumeN/A
Net Assets1.46B
American Funds American Balanced R3
Price$38.68
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
CSGCX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
CSGCX vs. RLBCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSGCX is a Buy and RLBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 266B vs. CSGCX (1.46B). RLBCX pays higher dividends than CSGCX: RLBCX (1.49) vs CSGCX (0.62). CSGCX was incepted earlier than RLBCX: CSGCX (32 years) vs RLBCX (23 years). CSGCX (1.66) is less costly to investors than RLBCX (0.89). CSGCX is a more actively managed with annual turnover of: 153.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than CSGCX: RLBCX (250) vs CSGCX (1000). RLBCX annual gain was more profitable for investors over the last year : 9.62 vs. CSGCX (6.93). RLBCX return over 5 years is better than : 40.56 vs. CSGCX (31.57).
CSGCXRLBCXCSGCX / RLBCX
Total Expense Ratio1.660.89187%
Annual Report Gross Expense Ratio1.660.89187%
Fund Existence32 years23 years-
Gain YTD8.95314.15863%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B266B1%
Annual Yield % from dividends0.621.4942%
Returns for 1 year6.939.6272%
Returns for 3 years46.5749.8293%
Returns for 5 years31.5740.5678%
Returns for 10 years55.0173.2975%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPWEF0.060.01
+28.35%
Opawica Explorations Inc.
RENXF0.18N/A
N/A
Renalytix plc
CLVSF19.28N/A
N/A
Cellavision AB
CRWKF63.99N/A
N/A
Cranswick PLC
OMVJF53.62-0.61
-1.12%
OMV AG